RBC Europe’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-109
| Closed | -$9.39K | – | 873 |
|
|
2021
Q3 | $9.39K | Sell |
109
-138
| -56% | -$11.9K | ﹤0.01% | 951 |
|
|
2021
Q2 | $27.5K | Hold |
247
| – | – | ﹤0.01% | 737 |
|
|
2021
Q1 | $27.5K | Buy |
247
+138
| +127% | +$15.4K | ﹤0.01% | 685 |
|
|
2020
Q4 | $11.6K | Sell |
109
-16
| -13% | -$1.7K | ﹤0.01% | 849 |
|
|
2020
Q3 | $17.4K | Sell |
125
-400
| -76% | -$55.6K | ﹤0.01% | 674 |
|
|
2020
Q2 | $170K | Buy |
525
+399
| +317% | +$129K | 0.01% | 263 |
|
|
2020
Q1 | $11.2K | Buy |
126
+97
| +334% | +$8.66K | ﹤0.01% | 680 |
|
|
2019
Q4 | $1.15K | Sell |
29
-417
| -93% | -$16.6K | ﹤0.01% | 985 |
|
|
2019
Q3 | $11K | Sell |
446
-1,039
| -70% | -$25.5K | ﹤0.01% | 771 |
|
|
2019
Q2 | $52.4K | Hold |
1,485
| – | – | 0.01% | 439 |
|
|
2019
Q1 | $66.5K | Sell |
1,485
-3,442
| -70% | -$154K | 0.01% | 406 |
|
|
2018
Q4 | $236K | Hold |
4,927
| – | – | 0.03% | 211 |
|
|
2018
Q3 | $329K | Hold |
4,927
| – | – | 0.04% | 194 |
|
|
2018
Q2 | $232K | Hold |
4,927
| – | – | 0.03% | 226 |
|
|
2018
Q1 | $278K | Hold |
4,927
| – | – | 0.03% | 210 |
|
|
2017
Q4 | $244K | Hold |
4,927
| – | – | 0.03% | 229 |
|
|
2017
Q3 | $375K | Buy |
+4,927
| New | +$375K | 0.05% | 178 |
|